These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

358 related articles for article (PubMed ID: 28767098)

  • 1. Chemical Modifications of Nucleic Acid Aptamers for Therapeutic Purposes.
    Ni S; Yao H; Wang L; Lu J; Jiang F; Lu A; Zhang G
    Int J Mol Sci; 2017 Aug; 18(8):. PubMed ID: 28767098
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Molecular Selection, Modification and Development of Therapeutic Oligonucleotide Aptamers.
    Yu Y; Liang C; Lv Q; Li D; Xu X; Liu B; Lu A; Zhang G
    Int J Mol Sci; 2016 Mar; 17(3):358. PubMed ID: 26978355
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Nanotechnology and aptamers: applications in drug delivery.
    Levy-Nissenbaum E; Radovic-Moreno AF; Wang AZ; Langer R; Farokhzad OC
    Trends Biotechnol; 2008 Aug; 26(8):442-9. PubMed ID: 18571753
    [TBL] [Abstract][Full Text] [Related]  

  • 4. RAID3--An interleukin-6 receptor-binding aptamer with post-selective modification-resistant affinity.
    Mittelberger F; Meyer C; Waetzig GH; Zacharias M; Valentini E; Svergun DI; Berg K; Lorenzen I; Grötzinger J; Rose-John S; Hahn U
    RNA Biol; 2015; 12(9):1043-53. PubMed ID: 26383776
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Nucleic acid-based aptamers: applications, development and clinical trials.
    Kanwar JR; Roy K; Maremanda NG; Subramanian K; Veedu RN; Bawa R; Kanwar RK
    Curr Med Chem; 2015; 22(21):2539-57. PubMed ID: 25723512
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Circular Bivalent Aptamers Enable in Vivo Stability and Recognition.
    Kuai H; Zhao Z; Mo L; Liu H; Hu X; Fu T; Zhang X; Tan W
    J Am Chem Soc; 2017 Jul; 139(27):9128-9131. PubMed ID: 28635257
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Nucleic acid aptamers: an emerging frontier in cancer therapy.
    Zhu G; Ye M; Donovan MJ; Song E; Zhao Z; Tan W
    Chem Commun (Camb); 2012 Nov; 48(85):10472-80. PubMed ID: 22951893
    [TBL] [Abstract][Full Text] [Related]  

  • 8. In vitro evolution of chemically-modified nucleic acid aptamers: Pros and cons, and comprehensive selection strategies.
    Lipi F; Chen S; Chakravarthy M; Rakesh S; Veedu RN
    RNA Biol; 2016 Dec; 13(12):1232-1245. PubMed ID: 27715478
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The development and testing of aptamers for cancer.
    Barbas AS; White RR
    Curr Opin Investig Drugs; 2009 Jun; 10(6):572-8. PubMed ID: 19513946
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Aptamer therapeutics advance.
    Lee JF; Stovall GM; Ellington AD
    Curr Opin Chem Biol; 2006 Jun; 10(3):282-9. PubMed ID: 16621675
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Aptamers: A Review of Their Chemical Properties and Modifications for Therapeutic Application.
    Adachi T; Nakamura Y
    Molecules; 2019 Nov; 24(23):. PubMed ID: 31766318
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Aptamers--basic research, drug development, and clinical applications.
    Proske D; Blank M; Buhmann R; Resch A
    Appl Microbiol Biotechnol; 2005 Dec; 69(4):367-74. PubMed ID: 16283295
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Advances in screening, synthesis, modification, and biomedical applications of peptides and peptide aptamers.
    Liu Y; Lu X; Chen M; Wei Z; Peng G; Yang J; Tang C; Yu P
    Biofactors; 2024; 50(1):33-57. PubMed ID: 37646383
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Advances in aptamers.
    Syed MA; Pervaiz S
    Oligonucleotides; 2010 Oct; 20(5):215-24. PubMed ID: 20677985
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The chemical biology of aptamers.
    Mayer G
    Angew Chem Int Ed Engl; 2009; 48(15):2672-89. PubMed ID: 19319884
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Aptamers as therapeutic middle molecules.
    Nakamura Y
    Biochimie; 2018 Feb; 145():22-33. PubMed ID: 29050945
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Locked nucleic acid aptamers.
    Barciszewski J; Medgaard M; Koch T; Kurreck J; Erdmann VA
    Methods Mol Biol; 2009; 535():165-86. PubMed ID: 19377996
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Aptamer-based assembly systems for SARS-CoV-2 detection and therapeutics.
    Dong Y; Wang J; Chen L; Chen H; Dang S; Li F
    Chem Soc Rev; 2024 Jul; 53(13):6830-6859. PubMed ID: 38829187
    [TBL] [Abstract][Full Text] [Related]  

  • 19. 2'-Deoxy purine, 2'-O-methyl pyrimidine (dRmY) aptamers as candidate therapeutics.
    Burmeister PE; Wang C; Killough JR; Lewis SD; Horwitz LR; Ferguson A; Thompson KM; Pendergrast PS; McCauley TG; Kurz M; Diener J; Cload ST; Wilson C; Keefe AD
    Oligonucleotides; 2006; 16(4):337-51. PubMed ID: 17155909
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Post-SELEX optimization of aptamers.
    Gao S; Zheng X; Jiao B; Wang L
    Anal Bioanal Chem; 2016 Jul; 408(17):4567-73. PubMed ID: 27173394
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.